Comment from Canadian Educators For Safe Technology
Posted by the Food and Drug Administration on Jan 19, 2022
I am the Director of a non-profit organization called Canadian Educators for Safe Technology. We have teacher advisors representing provinces across Canada. There are teachers across Canada who have experienced debilitating heart (Arrhythmia/heart failure), or brain (MS, Migraine) symptoms from wireless microwave radiation exposures in the workplace. I have a medical diagnosis: Electromagnetic Hypersensitivity. I have an intolerance to electromagnetic fields in the microwave range. All sources emitting Bluetooth or cellular signals negatively impact me with debilitating symptoms that can last for days. When I am not exposed to these wireless radiation triggers, I feel healthy. I love the outdoors, skiing, skating, sailing, hiking, etc. and I am supported by my family and friends. They use wired cell phones and wired devices around me to accommodate my disability. Discrimination in the workplace is prevalent and without wired accommodations and airplane mode cell phone/device policies, Electromagnetically Sensitive (EMS) people become unemployed and unable to function or participate in their communities. Many are forced out of their homes to live in cars and become separated from their families. My husband is a Professional Engineer (P.Eng.), my daughter is an Environmental Engineer and my son is a Web designer. We love technology! At home our technology is wired. Their cell phones are forwarded to our 4 landline phones. Wired tech is a simple solution and provides superior speeds/data privacy/energy & cost efficiency. Please see my attached my presentation to the Women’s College Hospital Medical Symposium, which provided medical accreditation to medical practitioners. Thank you kindly for supporting Electromagnetic Disabled people in the workplace and in their communities. Shelley Wright
Public comments supporting our petition are critical to helping us convince the FDA to take action. The FDA has opened a “docket” on our petition, and you are welcome to share your thoughts about this legal action on the FDA website. Our docket number is FDA-2021-P-1347.